Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial
Consensus Recommendations for the Management of Neurosarcoidosis
The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathology
<scp>ENLITE PD:</scp> A Randomized Clinical Trial of Light Therapy for Impaired Sleep in Parkinson's Disease
Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease
Increasing Neuroinflammation Relates to Increasing Neurodegeneration in People with HIV
Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease
Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors
Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: a CHARTER study
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021
Avoid or Embrace? Practice Effects in Alzheimer’s Disease Prevention Trials
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease
Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology
Definition and Consensus Diagnostic Criteria for Neurosarcoidosis
White matter damage, neuroinflammation, and neuronal integrity in HAND
Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States
The DIAN‐TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model
Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1
Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients
Factors Associated With the Onset and Persistence of Post–Lumbar Puncture Headache
CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease
Neurocognitive Change in the Era of HIV Combination Antiretroviral Therapy: The Longitudinal CHARTER Study
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline
Abdominal Obesity Contributes to Neurocognitive Impairment in HIV-Infected Patients With Increased Inflammation and Immune Activation
Randomized Trial of Central Nervous System–Targeted Antiretrovirals for HIV-Associated Neurocognitive Disorder
HIV DNA Reservoir Increases Risk for Cognitive Disorders in cART-Naïve Patients